Țară: Irlanda
Limbă: engleză
Sursă: HPRA (Health Products Regulatory Authority)
Meptazinol
Almirall, S.A.
N02AX; N02AX05
Meptazinol
200 milligram(s)
Film-coated tablet
Product subject to prescription which may not be renewed (A)
Other opioids; meptazinol
Marketed
1988-05-24
ARTWORK INFORMATION PANEL DESCRIPTION: PRINTING COLOURS NON PRINTING COLOURS COLOUR REFERENCE IN PMS BRIDGE EQUATE WITH CMYK PROOF: REGULATORY TEXT: ITEM NUMBER: MATERIAL SIZE: DESIGNER: FONTS: FONT SIZE: DATE: MANUFACTURER’S TECHNICAL CHECK: Manufacturer confirms the printability and technical compliance of this packaging material for correct use during packaging process. Date and Signature INLINE CONTROL CODE PIL Meptid 200mg tab GB_IE Mock up uk-pl-meptidtabs-Nov2018-tracked (1/2) Graphik Regular, GRAPHIK SEMIBOLD Mock up 170 x 220 mm 21.06.2019 8pt 1 Die cut P Black PACKAGE LEAFLET: INFORMATION FOR THE USER MEPTID 200 MG FILM-COATED TABLETS Meptazinol READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Meptid Tablets are and what they are used for 2. What you need to know before you take Meptid Tablets 3. How to take Meptid Tablets 4. Possible side effects 5 How to store Meptid Tablets 6. Contents of the pack and other information 1. WHAT MEPTID TABLETS ARE AND WHAT THEY ARE USED FOR The name of this medicine is Meptid 200 mg Film-Coated Tablets but will be referred to as Meptid Tablets throughout the remainder of the leaflet. Meptid Tablets belong to a group of medicines known as opioid analgesics, which are used to relieve pain. They contain meptazinol as the active ingredient. Meptid Tablets are used for the short-term treatment of moderate pain from a variety of causes. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE MEPTID TABLETS DO NOT TAKE MEPTID TABLETS IF YOU - are allergic to meptazinol or Citiți documentul complet
Health Products Regulatory Authority 28 January 2022 CRN00CS57 Page 1 of 6 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Meptid 200 mg film-coated Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 200 mg of meptazinol (as hydrochloride). Excipients: Sunset yellow (E110) 1.47 mg. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film-coated tablet Oval, biconvex, orange, film-coated tablets. The tablets are engraved ‘MPL 023’ on one side. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Meptid tablets are indicated for the short term treatment of moderate pain. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Prior to starting treatment with opioids, a discussion should be held with patients to put in place a strategy for ending treatment with meptazinol in order to minimise the risk of addiction and drug withdrawal syndrome (see section 4.4). Posology ADULTS 200 mg 3 to 6 hourly as required. Usually 1 tablet 4 hourly. ELDERLY The adult dosage schedule may be used in the elderly. PAEDIATRIC POPULATION No data are available. 4.3 CONTRAINDICATIONS ● Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. ● Patients with the following conditions: - acute alcoholism and where there is a risk of paralytic ileus - raised intracranial pressure or head injury (in addition to interfering with respiration, affects pupillary responses vital for neurological assessment) - acute respiratory depression - during an asthma attack - patients on monoamine-oxidase inhibitors (MAOIs) and for 14 days after discontinuing an MAOI. (see section 4.5) Health Products Regulatory Authority 28 January 2022 CRN00CS57 Page 2 of 6 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE Meptazinol has a favourable respiratory profile but caution should be exercised in patients whose respiratory system is already compromised. Patients with moderate to severe renal impairment should be given a reduced dose as the effect in these patients may be prolonged and Citiți documentul complet